Purdue startup developing novel treatment for life-threatening lung condition taking part in prominent accelerator program
Spirrow Therapeutics, a Purdue University-related startup, is developing a novel treatment for a life-threatening lung condition known as acute respiratory distress syndrome, or ARDS.